Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy.
Bartneck J, Hartmann AK, Stein L, Arnold-Schild D, Klein M, Stassen M, Marini F, Pielenhofer J, Meiser SL, Langguth P, Mack M, Muth S, Probst HC, Schild H, Radsak MP. Bartneck J, et al. Among authors: pielenhofer j. Front Immunol. 2023 Oct 2;14:1267866. doi: 10.3389/fimmu.2023.1267866. eCollection 2023. Front Immunol. 2023. PMID: 37849753 Free PMC article.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Hartmann AK, Bartneck J, Pielenhofer J, Meiser SL, Arnold-Schild D, Klein M, Stassen M, Schild H, Muth S, Probst HC, Langguth P, Grabbe S, Radsak MP. Hartmann AK, et al. Among authors: pielenhofer j. Front Immunol. 2023 Sep 1;14:1238861. doi: 10.3389/fimmu.2023.1238861. eCollection 2023. Front Immunol. 2023. PMID: 37727790 Free PMC article.